Portfolio

Portfolio

Portfolio

Portfolio

Portfolio News

Portfolio News

Portfolio News

Allurion Technologies
Allurion Expands Digital Offering For Patients and Providers in Response to COVID-19

NATICK, Mass.–(BUSINESS WIRE)–Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, is supporting customers around the world during COVID-19 with an expanded digital offering. The company’s weight loss program includes the world’s first and only procedureless gastric balloon, an individualized nutritional program, and a Bluetooth® smart scale and smartphone app that facilitate remote tracking. In response to recent data that indicates that individuals with obesity are at higher risk of poorer outcomes from COVID-19 and that quarantine measures may lead to weight gain, the company has expanded access to telenutrition for both existing…

Read More
Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies

Longitude Capital and other top-class VCs from around the world invest in Polares Medical. The Series B financing allows the company to advance its clinical studies. Polares Medical was spun off in 2017 from Symetis SA prior to the acquisition of Symetis by Boston Scientific. Polares Medical SA, a clinical stage medical technology company based in Lausanne announced today the closing of a $40 million financing led by Longitude Capital (Menlo Park) with the participation of Decheng Capital(Menlo Park / Shanghai), Endeavour Vision (Geneva), IDO Investments(Muscat), Earlybird Venture Capital (Berlin), and Wellington Partners(Munich). The company is focused on the development of a unique mitral valve hemi-replacement system to treat…

Read More
‘Prodigy’ founder taking Utah’s Teal Drones to unexplored heights
‘Prodigy’ founder taking Utah’s Teal Drones to unexplored heights

MURRAY — Smaller. Faster. Smarter. Common goals in the world of tech startups, but Teal Drones founder and CEO George Matus — having nailed these three attributes very early on with drones he and his team developed — is on a quest for something more elusive and, perhaps, more consequential. “Once consumer drones started becoming widely used and really popular, I started realizing that all they are is just a flying camera that can take photos and videos,” Matus said. “And, I’ve always had these grand visions of what drones could do … and the role for good that they…

Read More
Fractyl’s Revita DMR Same-Day Therapeutic Procedure Could End Daily Insulin Injections for Type 2 Diabetes Patients

Interim clinical data to be presented at ADA 2019 show that approximately 85 percent of patients are insulin-free at six months after Revita DMR outpatient therapy  LEXINGTON, Mass., June 8, 2019 — Fractyl Laboratories Inc. (Fractyl), today announced the presentation of interim data from the investigator-initiated INSPIRE clinical trial in collaboration with Fractyl showing Revita™ DMR, a same-day therapeutic procedure, can help eliminate the need for daily insulin injections for type 2 diabetes (T2D) patients. This data will be presented at the American Diabetes Association’s 79th Scientific Sessions in San Francisco on Sunday, June 9 from 12 pm to 1 pm….

Read More